Role of Non-Selective Beta-Adrenergic Blocker in Severe TBI
Clinical trial NCT06870370 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06870370
- Sponsor
- Tanta University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-20
- Primary completion
- 2025-09-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.